{"transactions":[{"id":4627093,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35883,"kind":"organization","name":"Philip & Daniele Barach Family Trust","position":1,"cik":"0002107059","reported_name":"Philip & Daniele Barach Family Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-09-25T20:59:56.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":1457765,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."}],"balance_after":1457765,"derivative":{"exercise_price":2,"exercise_date":"2026-09-23","expiration_date":"2027-09-30","underlying":"Class A Common Stock","underlying_shares":1457765},"source":{"system":"sec-edgar","filing":"0001104659-26-111028","document":"tm2626132-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2107059/000110465926111028/tm2626132-4_4seq1.xml","form_type":"4"}},{"id":4627092,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35883,"kind":"organization","name":"Philip & Daniele Barach Family Trust","position":1,"cik":"0002107059","reported_name":"Philip & Daniele Barach Family Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-09-25T20:59:56.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":1457765,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."}],"balance_after":1457765,"derivative":{"exercise_price":2,"exercise_date":"2026-09-23","expiration_date":"2027-09-30","underlying":"Class A Common Stock","underlying_shares":1457765},"source":{"system":"sec-edgar","filing":"0001104659-26-111028","document":"tm2626132-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2107059/000110465926111028/tm2626132-4_4seq1.xml","form_type":"4"}},{"id":4627091,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35883,"kind":"organization","name":"Philip & Daniele Barach Family Trust","position":1,"cik":"0002107059","reported_name":"Philip & Daniele Barach Family Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-09-25T20:59:56.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":1177000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants."}],"balance_after":1177000,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-23","expiration_date":"2031-09-23","underlying":"Class A Common Stock","underlying_shares":1177000},"source":{"system":"sec-edgar","filing":"0001104659-26-111028","document":"tm2626132-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2107059/000110465926111028/tm2626132-4_4seq1.xml","form_type":"4"}},{"id":4627090,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35883,"kind":"organization","name":"Philip & Daniele Barach Family Trust","position":1,"cik":"0002107059","reported_name":"Philip & Daniele Barach Family Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-09-25T20:59:56.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":2140000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."}],"balance_after":2140000,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-23","expiration_date":"2028-09-23","underlying":"Class A Common Stock","underlying_shares":2140000},"source":{"system":"sec-edgar","filing":"0001104659-26-111028","document":"tm2626132-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2107059/000110465926111028/tm2626132-4_4seq1.xml","form_type":"4"}},{"id":4627089,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35883,"kind":"organization","name":"Philip & Daniele Barach Family Trust","position":1,"cik":"0002107059","reported_name":"Philip & Daniele Barach Family Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-09-25T20:59:56.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":192771,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."}],"balance_after":2000000,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-23","expiration_date":"2028-09-23","underlying":"Class A Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001104659-26-111028","document":"tm2626132-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2107059/000110465926111028/tm2626132-4_4seq1.xml","form_type":"4"}},{"id":4627088,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35884,"kind":"person","name":"Barach Daniele Wolf","position":1,"cik":"0002126385","reported_name":"Barach Daniele Wolf","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-09-25T20:58:29.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":1457765,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"shares","element":"transactionShares","label":"F7","text":"Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Philip and Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":1457765,"derivative":{"exercise_price":2,"exercise_date":"2026-09-23","expiration_date":"2027-09-30","underlying":"Class A Common Stock","underlying_shares":1457765},"source":{"system":"sec-edgar","filing":"0001104659-26-111027","document":"tm2626132-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2126385/000110465926111027/tm2626132-3_4seq1.xml","form_type":"4"}},{"id":4627087,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35884,"kind":"person","name":"Barach Daniele Wolf","position":1,"cik":"0002126385","reported_name":"Barach Daniele Wolf","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-09-25T20:58:29.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":1457765,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Philip and Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":1457765,"derivative":{"exercise_price":2,"exercise_date":"2026-09-23","expiration_date":"2027-09-30","underlying":"Class A Common Stock","underlying_shares":1457765},"source":{"system":"sec-edgar","filing":"0001104659-26-111027","document":"tm2626132-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2126385/000110465926111027/tm2626132-3_4seq1.xml","form_type":"4"}},{"id":4627086,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35884,"kind":"person","name":"Barach Daniele Wolf","position":1,"cik":"0002126385","reported_name":"Barach Daniele Wolf","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-09-25T20:58:29.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":1177000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes.  No additional consideration was paid in connection with the issuance of such warrants."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes.  No additional consideration was paid in connection with the issuance of such warrants."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes.  No additional consideration was paid in connection with the issuance of such warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Philip and Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":1177000,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-23","expiration_date":"2031-09-23","underlying":"Class A Common Stock","underlying_shares":1177000},"source":{"system":"sec-edgar","filing":"0001104659-26-111027","document":"tm2626132-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2126385/000110465926111027/tm2626132-3_4seq1.xml","form_type":"4"}},{"id":4627085,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35884,"kind":"person","name":"Barach Daniele Wolf","position":1,"cik":"0002126385","reported_name":"Barach Daniele Wolf","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-09-25T20:58:29.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":2140000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Philip and Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":2140000,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-23","expiration_date":"2028-09-23","underlying":"Class A Common Stock","underlying_shares":2140000},"source":{"system":"sec-edgar","filing":"0001104659-26-111027","document":"tm2626132-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2126385/000110465926111027/tm2626132-3_4seq1.xml","form_type":"4"}},{"id":4627084,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35884,"kind":"person","name":"Barach Daniele Wolf","position":1,"cik":"0002126385","reported_name":"Barach Daniele Wolf","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-09-25T20:58:29.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":192771,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Philip and Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":2000000,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-23","expiration_date":"2028-09-23","underlying":"Class A Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001104659-26-111027","document":"tm2626132-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2126385/000110465926111027/tm2626132-3_4seq1.xml","form_type":"4"}},{"id":4627083,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35882,"kind":"person","name":"Barach Philip Alan","position":1,"cik":"0002106805","reported_name":"Barach Philip Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-09-25T20:57:42.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":1457765,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"shares","element":"transactionShares","label":"F7","text":"Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Philip and Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":1457765,"derivative":{"exercise_price":2,"exercise_date":"2026-09-23","expiration_date":"2027-09-30","underlying":"Class A Common Stock","underlying_shares":1457765},"source":{"system":"sec-edgar","filing":"0001104659-26-111026","document":"tm2626132-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2106805/000110465926111026/tm2626132-2_4seq1.xml","form_type":"4"}},{"id":4627082,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35882,"kind":"person","name":"Barach Philip Alan","position":1,"cik":"0002106805","reported_name":"Barach Philip Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-09-25T20:57:42.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":1457765,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the \"September 2027 Notes\") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Philip and Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":1457765,"derivative":{"exercise_price":2,"exercise_date":"2026-09-23","expiration_date":"2027-09-30","underlying":"Class A Common Stock","underlying_shares":1457765},"source":{"system":"sec-edgar","filing":"0001104659-26-111026","document":"tm2626132-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2106805/000110465926111026/tm2626132-2_4seq1.xml","form_type":"4"}},{"id":4627081,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35882,"kind":"person","name":"Barach Philip Alan","position":1,"cik":"0002106805","reported_name":"Barach Philip Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-09-25T20:57:42.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":1177000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Philip and Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":1177000,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-23","expiration_date":"2031-09-23","underlying":"Class A Common Stock","underlying_shares":1177000},"source":{"system":"sec-edgar","filing":"0001104659-26-111026","document":"tm2626132-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2106805/000110465926111026/tm2626132-2_4seq1.xml","form_type":"4"}},{"id":4627080,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35882,"kind":"person","name":"Barach Philip Alan","position":1,"cik":"0002106805","reported_name":"Barach Philip Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-09-25T20:57:42.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":2140000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the \"September 2026 Notes\") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Philip and Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":2140000,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-23","expiration_date":"2028-09-23","underlying":"Class A Common Stock","underlying_shares":2140000},"source":{"system":"sec-edgar","filing":"0001104659-26-111026","document":"tm2626132-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2106805/000110465926111026/tm2626132-2_4seq1.xml","form_type":"4"}},{"id":4627079,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35882,"kind":"person","name":"Barach Philip Alan","position":1,"cik":"0002106805","reported_name":"Barach Philip Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-09-25T20:57:42.000Z","date":"2026-09-23","kind":"other","planned":false,"acquired":true,"shares":192771,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Philip and Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":2000000,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-23","expiration_date":"2028-09-23","underlying":"Class A Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001104659-26-111026","document":"tm2626132-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2106805/000110465926111026/tm2626132-2_4seq1.xml","form_type":"4"}},{"id":728546,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35883,"kind":"organization","name":"Philip & Daniele Barach Family Trust","position":1,"cik":"0002107059","reported_name":"Philip & Daniele Barach Family Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-06-23T14:14:29.000Z","date":"2026-06-19","kind":"other","planned":false,"acquired":false,"shares":839160,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the \"Warrants\") that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the \"Notes\") that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the \"Warrants\") that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date."}],"balance_after":0,"derivative":{"exercise_price":2,"exercise_date":"2026-06-19","expiration_date":"2030-12-19","underlying":"Class A Common Stock","underlying_shares":839160},"source":{"system":"sec-edgar","filing":"0001104659-26-076683","document":"tm2618448-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000110465926076683/tm2618448-3_4seq1.xml","form_type":"4"}},{"id":728545,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35883,"kind":"organization","name":"Philip & Daniele Barach Family Trust","position":1,"cik":"0002107059","reported_name":"Philip & Daniele Barach Family Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-06-23T14:14:29.000Z","date":"2026-06-19","kind":"other","planned":false,"acquired":false,"shares":1204819,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the \"Notes\") that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the \"Notes\") that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration."}],"balance_after":0,"derivative":{"exercise_price":1.66,"exercise_date":"2025-12-19","expiration_date":"2026-12-31","underlying":"Class A Common Stock","underlying_shares":1204819},"source":{"system":"sec-edgar","filing":"0001104659-26-076683","document":"tm2618448-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000110465926076683/tm2618448-3_4seq1.xml","form_type":"4"}},{"id":728544,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35882,"kind":"person","name":"Barach Philip Alan","position":1,"cik":"0002106805","reported_name":"Barach Philip Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-06-23T14:13:54.000Z","date":"2026-06-19","kind":"other","planned":false,"acquired":false,"shares":839160,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the \"Warrants\") that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the \"Notes\") that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the \"Warrants\") that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Philip & Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":2,"exercise_date":"2026-06-19","expiration_date":"2030-12-19","underlying":"Class A Common Stock","underlying_shares":839160},"source":{"system":"sec-edgar","filing":"0001104659-26-076682","document":"tm2618448-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000110465926076682/tm2618448-2_4seq1.xml","form_type":"4"}},{"id":728543,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35882,"kind":"person","name":"Barach Philip Alan","position":1,"cik":"0002106805","reported_name":"Barach Philip Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-06-23T14:13:54.000Z","date":"2026-06-19","kind":"other","planned":false,"acquired":false,"shares":1204819,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the \"Notes\") that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the \"Notes\") that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Philip & Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":1.66,"exercise_date":"2025-12-19","expiration_date":"2026-12-31","underlying":"Class A Common Stock","underlying_shares":1204819},"source":{"system":"sec-edgar","filing":"0001104659-26-076682","document":"tm2618448-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000110465926076682/tm2618448-2_4seq1.xml","form_type":"4"}},{"id":728548,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35884,"kind":"person","name":"Barach Daniele Wolf","position":1,"cik":"0002126385","reported_name":"Barach Daniele Wolf","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2026-06-23T14:12:46.000Z","date":"2026-06-19","kind":"other","planned":false,"acquired":false,"shares":839160,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the \"Warrants\") that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the \"Notes\") that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the \"Warrants\") that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Philip & Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":2,"exercise_date":"2026-06-19","expiration_date":"2030-12-19","underlying":"Class A Common Stock","underlying_shares":839160},"source":{"system":"sec-edgar","filing":"0001104659-26-076681","document":"tm2618448-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000110465926076681/tm2618448-1_4seq1.xml","form_type":"4"}},{"id":728547,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":35884,"kind":"person","name":"Barach Daniele Wolf","position":1,"cik":"0002126385","reported_name":"Barach Daniele Wolf","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-06-23T14:12:46.000Z","date":"2026-06-19","kind":"other","planned":false,"acquired":false,"shares":1204819,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the \"Notes\") that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the \"Notes\") that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Philip & Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":1.66,"exercise_date":"2025-12-19","expiration_date":"2026-12-31","underlying":"Class A Common Stock","underlying_shares":1204819},"source":{"system":"sec-edgar","filing":"0001104659-26-076681","document":"tm2618448-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000110465926076681/tm2618448-1_4seq1.xml","form_type":"4"}},{"id":808437,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52471,"kind":"person","name":"Brigido Stephen","position":1,"cik":"0001869791","reported_name":"Brigido Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Functional Regeneration"}}],"security":"Restricted Stock Units","published_at":"2026-04-15T20:30:25.000Z","date":"2026-04-13","kind":"exercise","planned":false,"acquired":false,"shares":821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":821},"source":{"system":"sec-edgar","filing":"0001493152-26-016834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869791/000149315226016834/ownership.xml","form_type":"4"}},{"id":808436,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52471,"kind":"person","name":"Brigido Stephen","position":1,"cik":"0001869791","reported_name":"Brigido Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Functional Regeneration"}}],"security":"Class A Common Stock","published_at":"2026-04-15T20:30:25.000Z","date":"2026-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":268,"price":1.28,"value":343.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026."}],"balance_after":9474,"source":{"system":"sec-edgar","filing":"0001493152-26-016834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869791/000149315226016834/ownership.xml","form_type":"4"}},{"id":808435,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52471,"kind":"person","name":"Brigido Stephen","position":1,"cik":"0001869791","reported_name":"Brigido Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Functional Regeneration"}}],"security":"Class A Common Stock","published_at":"2026-04-15T20:30:25.000Z","date":"2026-04-13","kind":"exercise","planned":false,"acquired":true,"shares":821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."}],"balance_after":9742,"source":{"system":"sec-edgar","filing":"0001493152-26-016834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869791/000149315226016834/ownership.xml","form_type":"4"}},{"id":808030,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52384,"kind":"person","name":"Haines John R","position":1,"cik":"0001867686","reported_name":"Haines John R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Exec Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-04-15T20:30:23.000Z","date":"2026-04-13","kind":"exercise","planned":false,"acquired":false,"shares":1641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2026. The Class a common stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2026. The Class a common stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1641},"source":{"system":"sec-edgar","filing":"0001493152-26-016833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226016833/ownership.xml","form_type":"4"}},{"id":808029,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52384,"kind":"person","name":"Haines John R","position":1,"cik":"0001867686","reported_name":"Haines John R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Exec Vice President"}}],"security":"Class A Common Stock","published_at":"2026-04-15T20:30:23.000Z","date":"2026-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":583,"price":1.28,"value":746.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026."}],"balance_after":30179,"source":{"system":"sec-edgar","filing":"0001493152-26-016833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226016833/ownership.xml","form_type":"4"}},{"id":808028,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52384,"kind":"person","name":"Haines John R","position":1,"cik":"0001867686","reported_name":"Haines John R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Exec Vice President"}}],"security":"Class A Common Stock","published_at":"2026-04-15T20:30:23.000Z","date":"2026-04-13","kind":"exercise","planned":false,"acquired":true,"shares":1641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A common stock. On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A common stock. On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."}],"balance_after":30762,"source":{"system":"sec-edgar","filing":"0001493152-26-016833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226016833/ownership.xml","form_type":"4"}},{"id":808072,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-15T20:30:22.000Z","date":"2026-04-13","kind":"exercise","planned":false,"acquired":false,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3281},"source":{"system":"sec-edgar","filing":"0001493152-26-016832","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000149315226016832/ownership.xml","form_type":"4"}},{"id":808071,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-15T20:30:22.000Z","date":"2026-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1182,"price":1.28,"value":1512.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026."}],"balance_after":2853553,"source":{"system":"sec-edgar","filing":"0001493152-26-016832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000149315226016832/ownership.xml","form_type":"4"}},{"id":808070,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-15T20:30:22.000Z","date":"2026-04-13","kind":"exercise","planned":false,"acquired":true,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."}],"balance_after":2854735,"source":{"system":"sec-edgar","filing":"0001493152-26-016832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000149315226016832/ownership.xml","form_type":"4"}},{"id":938274,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T21:15:32.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."}],"balance_after":520021,"source":{"system":"sec-edgar","filing":"0001493152-26-002427","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226002427/ownership.xml","form_type":"4/A","original_submission_date":"2026-01-14"}},{"id":938273,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T21:15:29.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":19231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 19,231 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."}],"balance_after":256026,"source":{"system":"sec-edgar","filing":"0001493152-26-002424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226002424/ownership.xml","form_type":"4/A","original_submission_date":"2026-01-14"}},{"id":938328,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T16:15:31.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":20385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,385 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."}],"balance_after":394150,"source":{"system":"sec-edgar","filing":"0001493152-26-002425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315226002425/ownership.xml","form_type":"4/A","original_submission_date":"2026-01-14"}},{"id":938637,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69358,"kind":"person","name":"LeVien Vincent","position":1,"cik":"0002076464","reported_name":"LeVien Vincent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T16:15:29.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":28847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 28,847 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."}],"balance_after":153847,"source":{"system":"sec-edgar","filing":"0001493152-26-002423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2076464/000149315226002423/ownership.xml","form_type":"4/A","original_submission_date":"2026-01-14"}},{"id":939034,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T01:55:18.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":19231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 19,231 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":256026,"source":{"system":"sec-edgar","filing":"0001493152-26-002303","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226002303/ownership.xml","form_type":"4"}},{"id":939035,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T01:51:30.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":520021,"source":{"system":"sec-edgar","filing":"0001493152-26-002297","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226002297/ownership.xml","form_type":"4"}},{"id":939361,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69358,"kind":"person","name":"LeVien Vincent","position":1,"cik":"0002076464","reported_name":"LeVien Vincent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-14T20:53:00.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":28847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 28,847 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":153847,"source":{"system":"sec-edgar","filing":"0001493152-26-002300","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2076464/000149315226002300/ownership.xml","form_type":"4"}},{"id":939089,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-14T20:51:39.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":20385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,385 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":394150,"source":{"system":"sec-edgar","filing":"0001493152-26-002298","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315226002298/ownership.xml","form_type":"4"}},{"id":956969,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-30T21:30:30.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":156250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":1490996,"derivative":{"exercise_price":1.2,"expiration_date":"2035-12-29","underlying":"Class A Common Stock","underlying_shares":156250},"source":{"system":"sec-edgar","filing":"0001493152-25-029617","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225029617/ownership.xml","form_type":"4"}},{"id":956968,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-30T21:30:30.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":236795,"source":{"system":"sec-edgar","filing":"0001493152-25-029617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225029617/ownership.xml","form_type":"4"}},{"id":956967,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-30T21:30:28.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":156250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":518774,"derivative":{"exercise_price":1.2,"expiration_date":"2035-12-29","underlying":"Class A Common Stock","underlying_shares":156250},"source":{"system":"sec-edgar","filing":"0001493152-25-029615","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225029615/ownership.xml","form_type":"4"}},{"id":956966,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-30T21:30:28.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":490021,"source":{"system":"sec-edgar","filing":"0001493152-25-029615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225029615/ownership.xml","form_type":"4"}},{"id":957385,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69358,"kind":"person","name":"LeVien Vincent","position":1,"cik":"0002076464","reported_name":"LeVien Vincent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-30T16:30:32.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":156250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":156250,"derivative":{"exercise_price":1.2,"expiration_date":"2035-12-29","underlying":"Class A Common Stock","underlying_shares":156250},"source":{"system":"sec-edgar","filing":"0001493152-25-029618","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2076464/000149315225029618/ownership.xml","form_type":"4"}},{"id":957384,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69358,"kind":"person","name":"LeVien Vincent","position":1,"cik":"0002076464","reported_name":"LeVien Vincent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-30T16:30:32.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001493152-25-029618","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2076464/000149315225029618/ownership.xml","form_type":"4"}},{"id":957016,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-30T16:30:27.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":156250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":518774,"derivative":{"exercise_price":1.2,"expiration_date":"2035-12-29","underlying":"Class A Common Stock","underlying_shares":156250},"source":{"system":"sec-edgar","filing":"0001493152-25-029614","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225029614/ownership.xml","form_type":"4"}},{"id":957015,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-30T16:30:27.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":373765,"source":{"system":"sec-edgar","filing":"0001493152-25-029614","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225029614/ownership.xml","form_type":"4"}},{"id":960592,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-22T21:30:32.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":67416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested and became exercisable on December 19, 2025."}],"balance_after":365021,"source":{"system":"sec-edgar","filing":"0001493152-25-028787","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225028787/ownership.xml","form_type":"4"}},{"id":960591,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-22T21:30:23.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":67416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested on December 19, 2025."}],"balance_after":111795,"source":{"system":"sec-edgar","filing":"0001493152-25-028780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225028780/ownership.xml","form_type":"4"}},{"id":960666,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-22T16:30:18.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":67416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested on December 19, 2025."}],"balance_after":248765,"source":{"system":"sec-edgar","filing":"0001493152-25-028778","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225028778/ownership.xml","form_type":"4"}},{"id":990981,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-21T21:17:38.000Z","date":"2025-11-19","kind":"grant","planned":false,"acquired":true,"shares":61539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the date of grant."}],"balance_after":365021,"source":{"system":"sec-edgar","filing":"0001493152-25-024634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225024634/ownership.xml","form_type":"4"}},{"id":990979,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-21T21:15:25.000Z","date":"2025-11-19","kind":"grant","planned":false,"acquired":true,"shares":44379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the date of grant."}],"balance_after":111795,"source":{"system":"sec-edgar","filing":"0001493152-25-024631","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225024631/ownership.xml","form_type":"4"}},{"id":991609,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69358,"kind":"person","name":"LeVien Vincent","position":1,"cik":"0002076464","reported_name":"LeVien Vincent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-21T16:17:32.000Z","date":"2025-11-19","kind":"grant","planned":false,"acquired":true,"shares":3699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the date of grant."}],"balance_after":3699,"source":{"system":"sec-edgar","filing":"0001493152-25-024633","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2076464/000149315225024633/ownership.xml","form_type":"4"}},{"id":991078,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-21T16:15:24.000Z","date":"2025-11-19","kind":"grant","planned":false,"acquired":true,"shares":47042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the date of grant."}],"balance_after":248765,"source":{"system":"sec-edgar","filing":"0001493152-25-024630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225024630/ownership.xml","form_type":"4"}},{"id":1080764,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":2,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}},{"id":77141,"kind":"organization","name":"Resorts World Inc Pte. Ltd.","position":3,"cik":"0002007400","reported_name":"Resorts World Inc Pte. Ltd.","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-07-28T21:40:50.000Z","date":"2025-07-24","kind":"other","planned":false,"acquired":true,"shares":3700000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"kind","element":"transactionCoding","label":"F5","text":"In connection with Mr. Lim's purchase of a promissory note from the Issuer with an aggregate principal amount of $6,812,230, that bears interest at 2% per annum and has a maturity date of March 21, 2026, Mr. Lim received from the Issuer a warrant to purchase up to 3.7 million shares of the Issuer's Class A Common Stock, at an exercise price of $2.528 per share, which represents a 20% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In connection with Mr. Lim's purchase of a promissory note from the Issuer with an aggregate principal amount of $6,812,230, that bears interest at 2% per annum and has a maturity date of March 21, 2026, Mr. Lim received from the Issuer a warrant to purchase up to 3.7 million shares of the Issuer's Class A Common Stock, at an exercise price of $2.528 per share, which represents a 20% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This warrant is exercisable for five (5) years from (i) the date Mr. Lim receives clearance from the Committee on Foreign Investment in the United States (\"CFIUS\"), if such clearance is required for Mr. Lim to exercise this warrant, or (ii) the issuance date (July 21, 2025), if CFIUS clearance is not required for Mr. Lim to exercise this warrant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This warrant is exercisable for five (5) years from (i) the date Mr. Lim receives clearance from the Committee on Foreign Investment in the United States (\"CFIUS\"), if such clearance is required for Mr. Lim to exercise this warrant, or (ii) the issuance date (July 21, 2025), if CFIUS clearance is not required for Mr. Lim to exercise this warrant."}],"balance_after":3700000,"derivative":{"exercise_price":2.528,"underlying":"Class A Common Stock","underlying_shares":3700000},"source":{"system":"sec-edgar","filing":"0000905148-25-002572","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2007400/000090514825002572/form4.xml","form_type":"4"}},{"id":1080763,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":2,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}},{"id":77141,"kind":"organization","name":"Resorts World Inc Pte. Ltd.","position":3,"cik":"0002007400","reported_name":"Resorts World Inc Pte. Ltd.","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-07-28T21:40:50.000Z","date":"2025-07-24","kind":"other","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":false,"nature":"By Resorts World Inc Pte. Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"kind","element":"transactionCoding","label":"F4","text":"On July 24, 2025, the Issuer issued to RWI a new warrant to purchase up to 500,000 shares of the Issuer's Class A Common Stock at an exercise price of $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the Term Sheet."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 24, 2025, the Issuer issued to RWI a new warrant to purchase up to 500,000 shares of the Issuer's Class A Common Stock at an exercise price of $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the Term Sheet."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These warrants are held by Resorts World Inc Pte. Ltd. (\"RWI\"). Genting Berhad indirectly holds 50% of RWI with the balance 50% indirectly held by Mr. Lim. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":500000,"derivative":{"exercise_price":2.844,"exercise_date":"2025-07-24","expiration_date":"2030-07-24","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000905148-25-002572","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2007400/000090514825002572/form4.xml","form_type":"4"}},{"id":1080762,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":2,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}},{"id":77141,"kind":"organization","name":"Resorts World Inc Pte. Ltd.","position":3,"cik":"0002007400","reported_name":"Resorts World Inc Pte. Ltd.","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-07-28T21:40:50.000Z","date":"2025-07-24","kind":"other","planned":false,"acquired":true,"shares":1350000,"ownership":{"direct":false,"nature":"By Resorts World Inc Pte. Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer amended and restated the terms of these warrants to adjust the exercise price of these warrants to $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the binding term sheet (\"Term Sheet\") between the Issuer and RWI (defined in Footnote 3) dated February 12, 2025, a copy of which is filed as Exhibit 10.68 to Amendment No. 1 to Form S-1 filed by the Issuer with the SEC on February 13, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer amended and restated the terms of these warrants to adjust the exercise price of these warrants to $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the binding term sheet (\"Term Sheet\") between the Issuer and RWI (defined in Footnote 3) dated February 12, 2025, a copy of which is filed as Exhibit 10.68 to Amendment No. 1 to Form S-1 filed by the Issuer with the SEC on February 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These warrants are held by Resorts World Inc Pte. Ltd. (\"RWI\"). Genting Berhad indirectly holds 50% of RWI with the balance 50% indirectly held by Mr. Lim. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":1350000,"derivative":{"exercise_price":2.844,"exercise_date":"2024-07-15","expiration_date":"2029-07-15","underlying":"Class A Common Stock","underlying_shares":1350000},"source":{"system":"sec-edgar","filing":"0000905148-25-002572","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2007400/000090514825002572/form4.xml","form_type":"4"}},{"id":1080761,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":2,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}},{"id":77141,"kind":"organization","name":"Resorts World Inc Pte. Ltd.","position":3,"cik":"0002007400","reported_name":"Resorts World Inc Pte. Ltd.","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-07-28T21:40:50.000Z","date":"2025-07-24","kind":"other","planned":false,"acquired":false,"shares":1350000,"ownership":{"direct":false,"nature":"By Resorts World Inc Pte. Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer amended and restated the terms of these warrants to adjust the exercise price of these warrants to $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the binding term sheet (\"Term Sheet\") between the Issuer and RWI (defined in Footnote 3) dated February 12, 2025, a copy of which is filed as Exhibit 10.68 to Amendment No. 1 to Form S-1 filed by the Issuer with the SEC on February 13, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer amended and restated the terms of these warrants to adjust the exercise price of these warrants to $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the binding term sheet (\"Term Sheet\") between the Issuer and RWI (defined in Footnote 3) dated February 12, 2025, a copy of which is filed as Exhibit 10.68 to Amendment No. 1 to Form S-1 filed by the Issuer with the SEC on February 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These warrants are held by Resorts World Inc Pte. Ltd. (\"RWI\"). Genting Berhad indirectly holds 50% of RWI with the balance 50% indirectly held by Mr. Lim. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":2.988,"exercise_date":"2024-07-15","expiration_date":"2029-07-15","underlying":"Class A Common Stock","underlying_shares":1350000},"source":{"system":"sec-edgar","filing":"0000905148-25-002572","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2007400/000090514825002572/form4.xml","form_type":"4"}},{"id":1080760,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":2,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}},{"id":77141,"kind":"organization","name":"Resorts World Inc Pte. Ltd.","position":3,"cik":"0002007400","reported_name":"Resorts World Inc Pte. Ltd.","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-07-28T21:40:50.000Z","date":"2025-07-24","kind":"other","planned":false,"acquired":true,"shares":300000,"ownership":{"direct":false,"nature":"By Resorts World Inc Pte. Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer amended and restated the terms of these warrants to adjust the exercise price of these warrants to $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the binding term sheet (\"Term Sheet\") between the Issuer and RWI (defined in Footnote 3) dated February 12, 2025, a copy of which is filed as Exhibit 10.68 to Amendment No. 1 to Form S-1 filed by the Issuer with the SEC on February 13, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer amended and restated the terms of these warrants to adjust the exercise price of these warrants to $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the binding term sheet (\"Term Sheet\") between the Issuer and RWI (defined in Footnote 3) dated February 12, 2025, a copy of which is filed as Exhibit 10.68 to Amendment No. 1 to Form S-1 filed by the Issuer with the SEC on February 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These warrants are held by Resorts World Inc Pte. Ltd. (\"RWI\"). Genting Berhad indirectly holds 50% of RWI with the balance 50% indirectly held by Mr. Lim. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":300000,"derivative":{"exercise_price":2.844,"exercise_date":"2024-03-13","expiration_date":"2028-06-20","underlying":"Class A Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000905148-25-002572","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2007400/000090514825002572/form4.xml","form_type":"4"}},{"id":1080759,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":2,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}},{"id":77141,"kind":"organization","name":"Resorts World Inc Pte. Ltd.","position":3,"cik":"0002007400","reported_name":"Resorts World Inc Pte. Ltd.","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-07-28T21:40:50.000Z","date":"2025-07-24","kind":"other","planned":false,"acquired":false,"shares":300000,"ownership":{"direct":false,"nature":"By Resorts World Inc Pte. Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer amended and restated the terms of these warrants to adjust the exercise price of these warrants to $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the binding term sheet (\"Term Sheet\") between the Issuer and RWI (defined in Footnote 3) dated February 12, 2025, a copy of which is filed as Exhibit 10.68 to Amendment No. 1 to Form S-1 filed by the Issuer with the SEC on February 13, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer amended and restated the terms of these warrants to adjust the exercise price of these warrants to $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the binding term sheet (\"Term Sheet\") between the Issuer and RWI (defined in Footnote 3) dated February 12, 2025, a copy of which is filed as Exhibit 10.68 to Amendment No. 1 to Form S-1 filed by the Issuer with the SEC on February 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These warrants are held by Resorts World Inc Pte. Ltd. (\"RWI\"). Genting Berhad indirectly holds 50% of RWI with the balance 50% indirectly held by Mr. Lim. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.895,"exercise_date":"2024-03-13","expiration_date":"2028-06-20","underlying":"Class A Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000905148-25-002572","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2007400/000090514825002572/form4.xml","form_type":"4"}},{"id":1080758,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":2,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}},{"id":77141,"kind":"organization","name":"Resorts World Inc Pte. Ltd.","position":3,"cik":"0002007400","reported_name":"Resorts World Inc Pte. Ltd.","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-07-28T21:40:50.000Z","date":"2025-07-24","kind":"other","planned":false,"acquired":true,"shares":300000,"ownership":{"direct":false,"nature":"By Resorts World Inc Pte. Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer amended and restated the terms of these warrants to adjust the exercise price of these warrants to $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the binding term sheet (\"Term Sheet\") between the Issuer and RWI (defined in Footnote 3) dated February 12, 2025, a copy of which is filed as Exhibit 10.68 to Amendment No. 1 to Form S-1 filed by the Issuer with the SEC on February 13, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer amended and restated the terms of these warrants to adjust the exercise price of these warrants to $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the binding term sheet (\"Term Sheet\") between the Issuer and RWI (defined in Footnote 3) dated February 12, 2025, a copy of which is filed as Exhibit 10.68 to Amendment No. 1 to Form S-1 filed by the Issuer with the SEC on February 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These warrants are held by Resorts World Inc Pte. Ltd. (\"RWI\"). Genting Berhad indirectly holds 50% of RWI with the balance 50% indirectly held by Mr. Lim. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":300000,"derivative":{"exercise_price":2.844,"exercise_date":"2023-06-20","expiration_date":"2028-06-20","underlying":"Class A Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000905148-25-002572","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2007400/000090514825002572/form4.xml","form_type":"4"}},{"id":1080757,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":2,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}},{"id":77141,"kind":"organization","name":"Resorts World Inc Pte. Ltd.","position":3,"cik":"0002007400","reported_name":"Resorts World Inc Pte. Ltd.","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-07-28T21:40:50.000Z","date":"2025-07-24","kind":"other","planned":false,"acquired":false,"shares":300000,"ownership":{"direct":false,"nature":"By Resorts World Inc Pte. Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer amended and restated the terms of these warrants to adjust the exercise price of these warrants to $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the binding term sheet (\"Term Sheet\") between the Issuer and RWI (defined in Footnote 3) dated February 12, 2025, a copy of which is filed as Exhibit 10.68 to Amendment No. 1 to Form S-1 filed by the Issuer with the SEC on February 13, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer amended and restated the terms of these warrants to adjust the exercise price of these warrants to $2.844 per share, which represents a 10% discount from the closing price of the Issuer's Class A Common Stock on July 24, 2025, pursuant to the terms agreed upon in the binding term sheet (\"Term Sheet\") between the Issuer and RWI (defined in Footnote 3) dated February 12, 2025, a copy of which is filed as Exhibit 10.68 to Amendment No. 1 to Form S-1 filed by the Issuer with the SEC on February 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of each of these warrants, the exercise price was set on July 24, 2025, and accordingly the new warrants became \"derivative securities\" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")), and, for the amended and restated warrants, replaced the existing warrants at that time, thereby triggering a reporting obligation for each such warrant under Section 16 of the Exchange Act."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These warrants are held by Resorts World Inc Pte. Ltd. (\"RWI\"). Genting Berhad indirectly holds 50% of RWI with the balance 50% indirectly held by Mr. Lim. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":8.1,"exercise_date":"2023-06-20","expiration_date":"2028-06-20","underlying":"Class A Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000905148-25-002572","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007400/000090514825002572/form4.xml","form_type":"4"}},{"id":1080806,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69358,"kind":"person","name":"LeVien Vincent","position":1,"cik":"0002076464","reported_name":"LeVien Vincent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-07-28T16:30:06.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":186336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"62,112 options vest over 3 years beginning on June 5, 2026."}],"balance_after":186336,"derivative":{"exercise_price":1.92,"expiration_date":"2035-06-05","underlying":"Class A Common Stock","underlying_shares":186336},"source":{"system":"sec-edgar","filing":"0001641172-25-021166","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2076464/000164117225021166/ownership.xml","form_type":"4"}},{"id":1122486,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-04T20:30:33.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":false,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."}],"balance_after":3281,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3281},"source":{"system":"sec-edgar","filing":"0001641172-25-013629","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000164117225013629/ownership.xml","form_type":"4/A","original_submission_date":"2025-04-15"}},{"id":1122485,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-04T20:30:33.000Z","date":"2025-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1154,"price":1.64,"value":1892.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2025."}],"balance_after":2851454,"source":{"system":"sec-edgar","filing":"0001641172-25-013629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000164117225013629/ownership.xml","form_type":"4/A","original_submission_date":"2025-04-15"}},{"id":1122484,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-04T20:30:33.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":true,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."}],"balance_after":2852608,"source":{"system":"sec-edgar","filing":"0001641172-25-013629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000164117225013629/ownership.xml","form_type":"4/A","original_submission_date":"2025-04-15"}},{"id":1172244,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52471,"kind":"person","name":"Brigido Stephen","position":1,"cik":"0001869791","reported_name":"Brigido Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Functional Regeneration"}}],"security":"Restricted Stock Units","published_at":"2025-04-15T20:30:29.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":false,"shares":820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."}],"balance_after":820,"derivative":{"underlying":"Class A Common Stock","underlying_shares":820},"source":{"system":"sec-edgar","filing":"0001641172-25-004821","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869791/000164117225004821/ownership.xml","form_type":"4"}},{"id":1172243,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52471,"kind":"person","name":"Brigido Stephen","position":1,"cik":"0001869791","reported_name":"Brigido Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Functional Regeneration"}}],"security":"Class A Common Stock","published_at":"2025-04-15T20:30:29.000Z","date":"2025-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":268,"price":1.64,"value":439.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2025."}],"balance_after":8921,"source":{"system":"sec-edgar","filing":"0001641172-25-004821","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869791/000164117225004821/ownership.xml","form_type":"4"}},{"id":1172242,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52471,"kind":"person","name":"Brigido Stephen","position":1,"cik":"0001869791","reported_name":"Brigido Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Functional Regeneration"}}],"security":"Class A Common Stock","published_at":"2025-04-15T20:30:29.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":true,"shares":820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."}],"balance_after":9189,"source":{"system":"sec-edgar","filing":"0001641172-25-004821","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869791/000164117225004821/ownership.xml","form_type":"4"}},{"id":1171638,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-15T20:30:27.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":false,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."}],"balance_after":3281,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3281},"source":{"system":"sec-edgar","filing":"0001641172-25-004823","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000164117225004823/ownership.xml","form_type":"4"}},{"id":1171637,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-04-15T20:30:27.000Z","date":"2025-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1154,"price":1.64,"value":1892.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2025."}],"balance_after":20328,"source":{"system":"sec-edgar","filing":"0001641172-25-004823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000164117225004823/ownership.xml","form_type":"4"}},{"id":1171636,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-04-15T20:30:27.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":true,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."}],"balance_after":21482,"source":{"system":"sec-edgar","filing":"0001641172-25-004823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000164117225004823/ownership.xml","form_type":"4"}},{"id":1171603,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52384,"kind":"person","name":"Haines John R","position":1,"cik":"0001867686","reported_name":"Haines John R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Exec Vice President"}}],"security":"Restricted Stock Units","published_at":"2025-04-15T20:30:26.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":false,"shares":1641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2025. The Class a common stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2025. The Class a common stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."}],"balance_after":1641,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1641},"source":{"system":"sec-edgar","filing":"0001641172-25-004822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000164117225004822/ownership.xml","form_type":"4"}},{"id":1171602,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52384,"kind":"person","name":"Haines John R","position":1,"cik":"0001867686","reported_name":"Haines John R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Exec Vice President"}}],"security":"Class A Common Stock","published_at":"2025-04-15T20:30:26.000Z","date":"2025-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":577,"price":1.64,"value":946.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2025."}],"balance_after":29121,"source":{"system":"sec-edgar","filing":"0001641172-25-004822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000164117225004822/ownership.xml","form_type":"4"}},{"id":1171601,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52384,"kind":"person","name":"Haines John R","position":1,"cik":"0001867686","reported_name":"Haines John R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Exec Vice President"}}],"security":"Class A Common Stock","published_at":"2025-04-15T20:30:26.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":true,"shares":1641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A common stock. On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A common stock. On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."}],"balance_after":29698,"source":{"system":"sec-edgar","filing":"0001641172-25-004822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000164117225004822/ownership.xml","form_type":"4"}},{"id":1171882,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":80783,"kind":"person","name":"Beers David C","position":1,"cik":"0001869583","reported_name":"Beers David C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-15T16:30:24.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":false,"shares":1025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 4,101 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 4,101 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."}],"balance_after":1025,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1025},"source":{"system":"sec-edgar","filing":"0001641172-25-004820","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869583/000164117225004820/ownership.xml","form_type":"4"}},{"id":1171881,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":80783,"kind":"person","name":"Beers David C","position":1,"cik":"0001869583","reported_name":"Beers David C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-04-15T16:30:24.000Z","date":"2025-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":360,"price":1.64,"value":590.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2025."}],"balance_after":18201,"source":{"system":"sec-edgar","filing":"0001641172-25-004820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869583/000164117225004820/ownership.xml","form_type":"4"}},{"id":1171880,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":80783,"kind":"person","name":"Beers David C","position":1,"cik":"0001869583","reported_name":"Beers David C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-04-15T16:30:24.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":true,"shares":1025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 4,101 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 4,101 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."}],"balance_after":18561,"source":{"system":"sec-edgar","filing":"0001641172-25-004820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869583/000164117225004820/ownership.xml","form_type":"4"}},{"id":1235294,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-03T16:30:19.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":84746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":416459,"derivative":{"exercise_price":2.225,"expiration_date":"2034-12-19","underlying":"Class A Common Stock","underlying_shares":84746},"source":{"system":"sec-edgar","filing":"0001493152-25-008871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225008871/ownership.xml","form_type":"4/A","original_submission_date":"2025-01-06"}},{"id":1235293,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-03-03T16:30:19.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":67416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 67,416 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":201723,"source":{"system":"sec-edgar","filing":"0001493152-25-008871","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225008871/ownership.xml","form_type":"4/A","original_submission_date":"2025-01-06"}},{"id":1262041,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52471,"kind":"person","name":"Brigido Stephen","position":1,"cik":"0001869791","reported_name":"Brigido Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Functional Regeneration"}}],"security":"Restricted Stock Units","published_at":"2025-02-19T22:50:02.000Z","date":"2025-02-17","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 17, 2023, the reporting person was granted 10,000 RSUs, which vested on February 17, 2025. The Class A Common Stock into which such vested RSUs converted on February 17, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 17, 2023, the reporting person was granted 10,000 RSUs, which vested on February 17, 2025. The Class A Common Stock into which such vested RSUs converted on February 17, 2025 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-25-007614","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869791/000149315225007614/ownership.xml","form_type":"4"}},{"id":1262040,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52471,"kind":"person","name":"Brigido Stephen","position":1,"cik":"0001869791","reported_name":"Brigido Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Functional Regeneration"}}],"security":"Class A Common Stock","published_at":"2025-02-19T22:50:02.000Z","date":"2025-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3272,"price":2.14,"value":7002.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on February 17, 2025."}],"balance_after":8369,"source":{"system":"sec-edgar","filing":"0001493152-25-007614","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869791/000149315225007614/ownership.xml","form_type":"4"}},{"id":1262039,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52471,"kind":"person","name":"Brigido Stephen","position":1,"cik":"0001869791","reported_name":"Brigido Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Functional Regeneration"}}],"security":"Class A Common Stock","published_at":"2025-02-19T22:50:02.000Z","date":"2025-02-17","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On February 17, 2023, the reporting person was granted 10,000 RSUs, which vested on February 17, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on February 22,2023."}],"balance_after":11641,"source":{"system":"sec-edgar","filing":"0001493152-25-007614","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869791/000149315225007614/ownership.xml","form_type":"4"}},{"id":1258495,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52384,"kind":"person","name":"Haines John R","position":1,"cik":"0001867686","reported_name":"Haines John R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Exec Vice President"}}],"security":"Restricted Stock Units","published_at":"2025-02-19T22:00:19.000Z","date":"2025-02-17","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 17, 2023, the reporting person was granted 20,000 RSUs, which vested on February 17, 2025. The Class a common stock into which such vested RSUs converted on February 17, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 17, 2023, the reporting person was granted 20,000 RSUs, which vested on February 17, 2025. The Class a common stock into which such vested RSUs converted on February 17, 2025 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-25-007596","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225007596/ownership.xml","form_type":"4"}},{"id":1258494,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52384,"kind":"person","name":"Haines John R","position":1,"cik":"0001867686","reported_name":"Haines John R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Exec Vice President"}}],"security":"Class A Common Stock","published_at":"2025-02-19T22:00:19.000Z","date":"2025-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":7035,"price":2.14,"value":15054.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on February 17, 2025."}],"balance_after":28057,"source":{"system":"sec-edgar","filing":"0001493152-25-007596","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225007596/ownership.xml","form_type":"4"}},{"id":1258493,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":52384,"kind":"person","name":"Haines John R","position":1,"cik":"0001867686","reported_name":"Haines John R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Exec Vice President"}}],"security":"Class A Common Stock","published_at":"2025-02-19T22:00:19.000Z","date":"2025-02-17","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A common stock. On February 17, 2023, the reporting person was granted 20,000 RSUs, which vested on February 17, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on February 22, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A common stock. On February 17, 2023, the reporting person was granted 20,000 RSUs, which vested on February 17, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on February 22, 2023."}],"balance_after":35092,"source":{"system":"sec-edgar","filing":"0001493152-25-007596","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225007596/ownership.xml","form_type":"4"}},{"id":1260394,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":80783,"kind":"person","name":"Beers David C","position":1,"cik":"0001869583","reported_name":"Beers David C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-19T17:00:22.000Z","date":"2025-02-17","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 17, 2023, the reporting person was granted 12,500 RSUs, which vested on February 17, 2025. The Class A Common Stock into which such vested RSUs converted on February 17, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 17, 2023, the reporting person was granted 12,500 RSUs, which vested on February 17, 2025. The Class A Common Stock into which such vested RSUs converted on February 17, 2025 is reported in Table I on this Form 4."}],"derivative":{"underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-25-007599","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869583/000149315225007599/ownership.xml","form_type":"4"}},{"id":1260393,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":80783,"kind":"person","name":"Beers David C","position":1,"cik":"0001869583","reported_name":"Beers David C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-19T17:00:22.000Z","date":"2025-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":4396,"price":2.14,"value":9407.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on February 17, 2025."}],"balance_after":17536,"source":{"system":"sec-edgar","filing":"0001493152-25-007599","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869583/000149315225007599/ownership.xml","form_type":"4"}},{"id":1260392,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":80783,"kind":"person","name":"Beers David C","position":1,"cik":"0001869583","reported_name":"Beers David C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-19T17:00:22.000Z","date":"2025-02-17","kind":"exercise","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On February 17, 2023, the reporting person was granted 12,500 RSUs, which vested on February 17, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on February 22,2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On February 17, 2023, the reporting person was granted 12,500 RSUs, which vested on February 17, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on February 22,2023."}],"balance_after":21932,"source":{"system":"sec-edgar","filing":"0001493152-25-007599","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869583/000149315225007599/ownership.xml","form_type":"4"}},{"id":1292993,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":83824,"kind":"organization","name":"Dragasac Ltd","position":2,"cik":"0001872884","reported_name":"Dragasac Ltd","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":3,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-01-28T16:45:32.000Z","date":"2025-01-24","kind":"other","planned":false,"acquired":false,"shares":652981,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Dragasac Limited"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly held by Dragasac Limited (\"Dragasac\"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":2.07,"exercise_date":"2024-01-16","expiration_date":"2030-03-16","underlying":"Class A Common Stock","underlying_shares":652981},"source":{"system":"sec-edgar","filing":"0000905148-25-000224","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1470308/000090514825000224/form4.xml","form_type":"4"}},{"id":1292992,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":83824,"kind":"organization","name":"Dragasac Ltd","position":2,"cik":"0001872884","reported_name":"Dragasac Ltd","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":3,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-01-28T16:45:32.000Z","date":"2025-01-24","kind":"other","planned":false,"acquired":false,"shares":535274,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Dragasac Limited"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly held by Dragasac Limited (\"Dragasac\"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":2.07,"exercise_date":"2024-01-16","expiration_date":"2029-01-16","underlying":"Class A Common Stock","underlying_shares":535274},"source":{"system":"sec-edgar","filing":"0000905148-25-000224","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1470308/000090514825000224/form4.xml","form_type":"4"}},{"id":1292991,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":83824,"kind":"organization","name":"Dragasac Ltd","position":2,"cik":"0001872884","reported_name":"Dragasac Ltd","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":3,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-01-28T16:45:32.000Z","date":"2025-01-24","kind":"other","planned":false,"acquired":true,"shares":652981,"ownership":{"direct":false,"nature":"By Dragasac Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly held by Dragasac Limited (\"Dragasac\"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":652981,"derivative":{"exercise_price":2.07,"exercise_date":"2024-01-16","expiration_date":"2030-03-16","underlying":"Class A Common Stock","underlying_shares":652981},"source":{"system":"sec-edgar","filing":"0000905148-25-000224","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1470308/000090514825000224/form4.xml","form_type":"4"}},{"id":1292990,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":83824,"kind":"organization","name":"Dragasac Ltd","position":2,"cik":"0001872884","reported_name":"Dragasac Ltd","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":3,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-01-28T16:45:32.000Z","date":"2025-01-24","kind":"other","planned":false,"acquired":false,"shares":652981,"ownership":{"direct":false,"nature":"By Dragasac Limited"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly held by Dragasac Limited (\"Dragasac\"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":2.4898,"exercise_date":"2024-01-16","expiration_date":"2030-03-16","underlying":"Class A Common Stock","underlying_shares":652981},"source":{"system":"sec-edgar","filing":"0000905148-25-000224","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1470308/000090514825000224/form4.xml","form_type":"4"}},{"id":1292989,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":83824,"kind":"organization","name":"Dragasac Ltd","position":2,"cik":"0001872884","reported_name":"Dragasac Ltd","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":3,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-01-28T16:45:32.000Z","date":"2025-01-24","kind":"other","planned":false,"acquired":true,"shares":535274,"ownership":{"direct":false,"nature":"By Dragasac Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly held by Dragasac Limited (\"Dragasac\"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":535274,"derivative":{"exercise_price":2.07,"exercise_date":"2024-01-16","expiration_date":"2029-01-16","underlying":"Class A Common Stock","underlying_shares":535274},"source":{"system":"sec-edgar","filing":"0000905148-25-000224","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1470308/000090514825000224/form4.xml","form_type":"4"}},{"id":1292988,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":83824,"kind":"organization","name":"Dragasac Ltd","position":2,"cik":"0001872884","reported_name":"Dragasac Ltd","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":3,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}}],"security":"Warrants (Right to Buy)","published_at":"2025-01-28T16:45:32.000Z","date":"2025-01-24","kind":"other","planned":false,"acquired":false,"shares":535274,"ownership":{"direct":false,"nature":"By Dragasac Limited"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly held by Dragasac Limited (\"Dragasac\"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":2.4898,"exercise_date":"2024-01-16","expiration_date":"2029-01-16","underlying":"Class A Common Stock","underlying_shares":535274},"source":{"system":"sec-edgar","filing":"0000905148-25-000224","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1470308/000090514825000224/form4.xml","form_type":"4"}},{"id":1292987,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":83824,"kind":"organization","name":"Dragasac Ltd","position":2,"cik":"0001872884","reported_name":"Dragasac Ltd","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":3,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2025-01-28T16:45:32.000Z","date":"2025-01-24","kind":"other","planned":false,"acquired":true,"shares":652981,"price":2.07,"value":1351670.67,"ownership":{"direct":false,"nature":"By Dragasac Limited"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly held by Dragasac Limited (\"Dragasac\"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":6335630,"source":{"system":"sec-edgar","filing":"0000905148-25-000224","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1470308/000090514825000224/form4.xml","form_type":"4"}},{"id":1292986,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":77139,"kind":"person","name":"Lim Kok Thay","position":1,"cik":"0001470308","reported_name":"Lim Kok Thay","relationship":{"ten_percent_owner":true}},{"id":83824,"kind":"organization","name":"Dragasac Ltd","position":2,"cik":"0001872884","reported_name":"Dragasac Ltd","relationship":{"ten_percent_owner":true}},{"id":77140,"kind":"person","name":"Genting Berhad","position":3,"cik":"0001788489","reported_name":"Genting Berhad","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2025-01-28T16:45:32.000Z","date":"2025-01-24","kind":"other","planned":false,"acquired":true,"shares":535274,"price":2.07,"value":1108017.18,"ownership":{"direct":false,"nature":"By Dragasac Limited"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly held by Dragasac Limited (\"Dragasac\"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":5682649,"source":{"system":"sec-edgar","filing":"0000905148-25-000224","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470308/000090514825000224/form4.xml","form_type":"4"}},{"id":1307456,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T21:05:29.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":84746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":362524,"derivative":{"exercise_price":2.225,"expiration_date":"2034-12-19","underlying":"Class A Common Stock","underlying_shares":84746},"source":{"system":"sec-edgar","filing":"0001493152-25-001221","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225001221/ownership.xml","form_type":"4"}},{"id":1307455,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-01-07T21:05:29.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":67416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 67,416 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":303482,"source":{"system":"sec-edgar","filing":"0001493152-25-001221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225001221/ownership.xml","form_type":"4"}},{"id":1309598,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T02:51:24.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":84746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":1334746,"derivative":{"exercise_price":2.225,"expiration_date":"2034-12-19","underlying":"Class A Common Stock","underlying_shares":84746},"source":{"system":"sec-edgar","filing":"0001493152-25-001099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225001099/ownership.xml","form_type":"4"}},{"id":1309597,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-01-07T02:51:24.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":67416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 67,416 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":67416,"source":{"system":"sec-edgar","filing":"0001493152-25-001099","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225001099/ownership.xml","form_type":"4"}}],"next_cursor":"2025-01-07T02:51:24.000000Z,1309597"}